Aviva (OTCMKTS:AVVIY) Hits New 1-Year High - Should You Buy?

Key Points

• Aviva PLC shares reached a new 52-week high, trading at a peak of $17.76, during which 18,369 shares were exchanged.
• Analyst ratings for Aviva show mixed views, with Barclays downgraded the stock to a "hold," while Citigroup upgraded it to the same rating, leading to a consensus of "Moderate Buy."
• The company's financial health is stable, highlighted by a debt-to-equity ratio of 0.67 and a strong current and quick ratio both at 1.86.

Shares of Aviva PLC (OTCMKTS:AVVIY - Get Free Report) hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $17.76 and last traded at $17.74, with a volume of 18369 shares traded. The stock had previously closed at $17.51.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on AVVIY shares. Barclays cut Aviva from a "strong-buy" rating to a "hold" rating in a report on Monday, June 16th. Citigroup upgraded Aviva to a "hold" rating in a research report on Tuesday, July 15th. Three analysts have rated the stock with a hold rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, Aviva has a consensus rating of "Moderate Buy".

Aviva Stock Up 1.5%

The company has a debt-to-equity ratio of 0.67, a current ratio of 1.86 and a quick ratio of 1.86. The company has a 50-day moving average of $17.10 and a 200 day moving average of $15.16.

Aviva Company Profile

Aviva plc provides various insurance, retirement, investment, and savings products in the United Kingdom, Ireland, Canada, and internationally. The company offers life insurance, long-term health and accident insurance, savings, pension, and annuity products, as well as pension fund business and lifetime mortgage products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.